MaxQ AI, which is commercializing an AI-based medical imaging platform, withdrew its plans for a US initial public offering on Friday. The pre-revenue company had filed in August 2018 to raise $8 million. The company did not disclose a reason for its IPO withdrawal.
The Tel Aviv, Israel-based company was founded in 2013 and had planned to list on the Nasdaq under the symbol MQAI. ViewTrade was set to be the sole bookrunner on the deal.
